Home > Formulary : Paediatric > Paediatric Chapters > 7. Obstetrics, gynaecology, and urinary-tract disorders >
BNSSG Paediatric Joint Formulary
7.1 Bladder and urinary disorders
Last edited: 15-04-2024
7.1.1 Urinary frequency, enuresis, and incontinence
First line drugs |
Second line drugs |
Specialist drugs |
Secondary care drugs |
Antimuscarinics
First line:
Oxybutynin standard-release (TLS Amber Specialist Recommended)
Second line:
Oxybutynin modified-release (TLS Amber Specialist Recommended)
Tolterodine (standard-release & modified-release) (TLS Amber Specialist Recommended)
Third line:
Solifenacin (TLS Amber Specialist Recommended)
Oxybutynin (transdermal) (TLS Red)
Beta3-adrenoceptor Agonists
Mirabegron (TLS Amber 3 months)
Vassopressin Analogues
Desmopressin (oral tablets/oral lyophilisates) (TLS Green)
For primary nocturnal enuresis
Other
Botulinum toxin type A (TLS Red)
- For urinary incontinence/overactive bladder in children where oral antimuscarinic treatments have failed
See Botulinum Toxin A Pathways page for more information
7.1.2 Urinary retention
Alpha-adrenoceptor Blockers
Doxazosin (standard-release) (TLS Red)
Tamsulosin capsules (modified-release) (TLS Red)
7.1.3 Urological pain
Alkalinising Drugs
Potassium citrate (TLS Green)
Sodium bicarbonate (TLS Green)